Chapter/Section Purchase

1 Study Coverage
1.1 Primary Care POC Diagnostics Revenue in Primary Care POC Diagnostics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Primary Care POC Diagnostics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Primary Care POC Diagnostics Market Size for the Year 2017-2028
1.2.2 Global Primary Care POC Diagnostics Market Size for the Year 2017-2028
1.3 Primary Care POC Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Primary Care POC Diagnostics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Primary Care POC Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Primary Care POC Diagnostics Market Dynamics
1.4.1 Primary Care POC Diagnostics Industry Trends
1.4.2 Primary Care POC Diagnostics Market Drivers
1.4.3 Primary Care POC Diagnostics Market Challenges
1.4.4 Primary Care POC Diagnostics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Primary Care POC Diagnostics by Type
2.1 Primary Care POC Diagnostics Market Segment by Type
2.1.1 Glucose Testing
2.1.2 Hb1Ac
2.1.3 Coagulation
2.1.4 Fertility
2.2 Global Primary Care POC Diagnostics Market Size by Type (2017, 2022 & 2028)
2.3 Global Primary Care POC Diagnostics Market Size by Type (2017-2028)
2.4 United States Primary Care POC Diagnostics Market Size by Type (2017, 2022 & 2028)
2.5 United States Primary Care POC Diagnostics Market Size by Type (2017-2028)
3 Primary Care POC Diagnostics by Application
3.1 Primary Care POC Diagnostics Market Segment by Application
3.1.1 Pharmacy & Retail Clinics
3.1.2 Physician Office
3.1.3 Urgent Care Clinics
3.1.4 Non-practice Clinics
3.1.5 Cardiac Markers
3.2 Global Primary Care POC Diagnostics Market Size by Application (2017, 2022 & 2028)
3.3 Global Primary Care POC Diagnostics Market Size by Application (2017-2028)
3.4 United States Primary Care POC Diagnostics Market Size by Application (2017, 2022 & 2028)
3.5 United States Primary Care POC Diagnostics Market Size by Application (2017-2028)
4 Global Primary Care POC Diagnostics Competitor Landscape by Company
4.1 Global Primary Care POC Diagnostics Market Size by Company
4.1.1 Top Global Primary Care POC Diagnostics Companies Ranked by Revenue (2021)
4.1.2 Global Primary Care POC Diagnostics Revenue by Player (2017-2022)
4.2 Global Primary Care POC Diagnostics Concentration Ratio (CR)
4.2.1 Primary Care POC Diagnostics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Primary Care POC Diagnostics in 2021
4.2.3 Global Primary Care POC Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Primary Care POC Diagnostics Headquarters, Revenue in Primary Care POC Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Primary Care POC Diagnostics Headquarters and Area Served
4.3.2 Global Primary Care POC Diagnostics Companies Revenue in Primary Care POC Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Primary Care POC Diagnostics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Primary Care POC Diagnostics Market Size by Company
4.5.1 Top Primary Care POC Diagnostics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Primary Care POC Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Primary Care POC Diagnostics Market Size by Region
5.1 Global Primary Care POC Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Primary Care POC Diagnostics Market Size by Region (2017-2028)
5.2.1 Global Primary Care POC Diagnostics Market Size by Region: 2017-2022
5.2.2 Global Primary Care POC Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Primary Care POC Diagnostics Market Size YoY Growth 2017-2028
6.1.2 North America Primary Care POC Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Primary Care POC Diagnostics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Primary Care POC Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Primary Care POC Diagnostics Market Size YoY Growth 2017-2028
6.3.2 Europe Primary Care POC Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Primary Care POC Diagnostics Market Size YoY Growth 2017-2028
6.4.2 Latin America Primary Care POC Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Primary Care POC Diagnostics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Primary Care POC Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Details
7.1.2 Abbott Business Overview
7.1.3 Abbott Primary Care POC Diagnostics Introduction
7.1.4 Abbott Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.1.5 Abbott Recent Development
7.2 ADI/American Diagnostica
7.2.1 ADI/American Diagnostica Company Details
7.2.2 ADI/American Diagnostica Business Overview
7.2.3 ADI/American Diagnostica Primary Care POC Diagnostics Introduction
7.2.4 ADI/American Diagnostica Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.2.5 ADI/American Diagnostica Recent Development
7.3 Agilent Technologies
7.3.1 Agilent Technologies Company Details
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Primary Care POC Diagnostics Introduction
7.3.4 Agilent Technologies Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.3.5 Agilent Technologies Recent Development
7.4 Alere/Biosite/Inverness
7.4.1 Alere/Biosite/Inverness Company Details
7.4.2 Alere/Biosite/Inverness Business Overview
7.4.3 Alere/Biosite/Inverness Primary Care POC Diagnostics Introduction
7.4.4 Alere/Biosite/Inverness Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.4.5 Alere/Biosite/Inverness Recent Development
7.5 Axis-Shield
7.5.1 Axis-Shield Company Details
7.5.2 Axis-Shield Business Overview
7.5.3 Axis-Shield Primary Care POC Diagnostics Introduction
7.5.4 Axis-Shield Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.5.5 Axis-Shield Recent Development
7.6 Beckman Coulter/Danaher
7.6.1 Beckman Coulter/Danaher Company Details
7.6.2 Beckman Coulter/Danaher Business Overview
7.6.3 Beckman Coulter/Danaher Primary Care POC Diagnostics Introduction
7.6.4 Beckman Coulter/Danaher Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.6.5 Beckman Coulter/Danaher Recent Development
7.7 Becton Dickinson
7.7.1 Becton Dickinson Company Details
7.7.2 Becton Dickinson Business Overview
7.7.3 Becton Dickinson Primary Care POC Diagnostics Introduction
7.7.4 Becton Dickinson Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.7.5 Becton Dickinson Recent Development
7.8 Bio/Data
7.8.1 Bio/Data Company Details
7.8.2 Bio/Data Business Overview
7.8.3 Bio/Data Primary Care POC Diagnostics Introduction
7.8.4 Bio/Data Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.8.5 Bio/Data Recent Development
7.9 Decode Genetics
7.9.1 Decode Genetics Company Details
7.9.2 Decode Genetics Business Overview
7.9.3 Decode Genetics Primary Care POC Diagnostics Introduction
7.9.4 Decode Genetics Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.9.5 Decode Genetics Recent Development
7.10 Diadexus
7.10.1 Diadexus Company Details
7.10.2 Diadexus Business Overview
7.10.3 Diadexus Primary Care POC Diagnostics Introduction
7.10.4 Diadexus Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.10.5 Diadexus Recent Development
7.11 Diagnocure
7.11.1 Diagnocure Company Details
7.11.2 Diagnocure Business Overview
7.11.3 Diagnocure Primary Care POC Diagnostics Introduction
7.11.4 Diagnocure Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.11.5 Diagnocure Recent Development
7.12 Diagnostica Stago/Trinity Biotech
7.12.1 Diagnostica Stago/Trinity Biotech Company Details
7.12.2 Diagnostica Stago/Trinity Biotech Business Overview
7.12.3 Diagnostica Stago/Trinity Biotech Primary Care POC Diagnostics Introduction
7.12.4 Diagnostica Stago/Trinity Biotech Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.12.5 Diagnostica Stago/Trinity Biotech Recent Development
7.13 Diamedix
7.13.1 Diamedix Company Details
7.13.2 Diamedix Business Overview
7.13.3 Diamedix Primary Care POC Diagnostics Introduction
7.13.4 Diamedix Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.13.5 Diamedix Recent Development
7.14 Polymedco
7.14.1 Polymedco Company Details
7.14.2 Polymedco Business Overview
7.14.3 Polymedco Primary Care POC Diagnostics Introduction
7.14.4 Polymedco Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.14.5 Polymedco Recent Development
7.15 Qiagen
7.15.1 Qiagen Company Details
7.15.2 Qiagen Business Overview
7.15.3 Qiagen Primary Care POC Diagnostics Introduction
7.15.4 Qiagen Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.15.5 Qiagen Recent Development
7.16 Roche
7.16.1 Roche Company Details
7.16.2 Roche Business Overview
7.16.3 Roche Primary Care POC Diagnostics Introduction
7.16.4 Roche Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.16.5 Roche Recent Development
7.17 SDIX
7.17.1 SDIX Company Details
7.17.2 SDIX Business Overview
7.17.3 SDIX Primary Care POC Diagnostics Introduction
7.17.4 SDIX Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.17.5 SDIX Recent Development
7.18 Sequenom
7.18.1 Sequenom Company Details
7.18.2 Sequenom Business Overview
7.18.3 Sequenom Primary Care POC Diagnostics Introduction
7.18.4 Sequenom Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.18.5 Sequenom Recent Development
7.19 Siemens
7.19.1 Siemens Company Details
7.19.2 Siemens Business Overview
7.19.3 Siemens Primary Care POC Diagnostics Introduction
7.19.4 Siemens Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.19.5 Siemens Recent Development
7.20 Sienco
7.20.1 Sienco Company Details
7.20.2 Sienco Business Overview
7.20.3 Sienco Primary Care POC Diagnostics Introduction
7.20.4 Sienco Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.20.5 Sienco Recent Development
7.21 Sysmex
7.21.1 Sysmex Company Details
7.21.2 Sysmex Business Overview
7.21.3 Sysmex Primary Care POC Diagnostics Introduction
7.21.4 Sysmex Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.21.5 Sysmex Recent Development
7.22 Takara Bio
7.22.1 Takara Bio Company Details
7.22.2 Takara Bio Business Overview
7.22.3 Takara Bio Primary Care POC Diagnostics Introduction
7.22.4 Takara Bio Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.22.5 Takara Bio Recent Development
7.23 ThermoFisher
7.23.1 ThermoFisher Company Details
7.23.2 ThermoFisher Business Overview
7.23.3 ThermoFisher Primary Care POC Diagnostics Introduction
7.23.4 ThermoFisher Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.23.5 ThermoFisher Recent Development
7.24 Tosoh
7.24.1 Tosoh Company Details
7.24.2 Tosoh Business Overview
7.24.3 Tosoh Primary Care POC Diagnostics Introduction
7.24.4 Tosoh Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.24.5 Tosoh Recent Development
7.25 Wako
7.25.1 Wako Company Details
7.25.2 Wako Business Overview
7.25.3 Wako Primary Care POC Diagnostics Introduction
7.25.4 Wako Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.25.5 Wako Recent Development
7.26 Zycare/Alere
7.26.1 Zycare/Alere Company Details
7.26.2 Zycare/Alere Business Overview
7.26.3 Zycare/Alere Primary Care POC Diagnostics Introduction
7.26.4 Zycare/Alere Revenue in Primary Care POC Diagnostics Business (2017-2022)
7.26.5 Zycare/Alere Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer